As pharmaceutical commercialization strategies evolve alongside digital transformation and AI-enabled content creation, regulatory fluency and agility is essential.

This session will provide an overview of the current Canadian regulatory and self-regulatory landscape, explore how guidance is shifting alongside new technologies, and share strategies for working effectively with the Pharmaceutical Advertising Advisory Board (PAAB) and the Advertising Standards Canada (ASC).

Learn how to move beyond viewing compliance solely as a risk mitigation function to a strategic capability that enables agility, responsible innovation and more trust through transparent and patient-centric engagement strategies.